REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,100,800 | +3.5% | 1,810,000 | 0.0% | 5.54% | +31.1% |
Q2 2023 | $48,417,500 | +23.5% | 1,810,000 | 0.0% | 4.23% | +31.0% |
Q1 2023 | $39,204,600 | -34.8% | 1,810,000 | -28.3% | 3.23% | -30.7% |
Q4 2022 | $60,145,500 | +20.9% | 2,525,000 | +0.1% | 4.66% | +42.6% |
Q3 2022 | $49,740,000 | +7.7% | 2,522,300 | +6.4% | 3.27% | -16.4% |
Q2 2022 | $46,191,000 | -23.6% | 2,370,000 | 0.0% | 3.91% | +44.1% |
Q1 2022 | $60,459,000 | +1.4% | 2,370,000 | 0.0% | 2.71% | +61.3% |
Q4 2021 | $59,653,000 | -22.6% | 2,370,000 | -15.4% | 1.68% | -12.3% |
Q3 2021 | $77,028,000 | +5.3% | 2,800,000 | +21.5% | 1.92% | +3.2% |
Q2 2021 | $73,161,000 | -13.5% | 2,305,000 | +25.0% | 1.86% | -26.3% |
Q1 2021 | $84,627,000 | +30.8% | 1,844,535 | +12.8% | 2.52% | +31.5% |
Q4 2020 | $64,711,000 | +13.8% | 1,634,535 | 0.0% | 1.92% | -24.7% |
Q3 2020 | $56,882,000 | +35.0% | 1,634,535 | +22.5% | 2.55% | +2.2% |
Q2 2020 | $42,131,000 | +45.7% | 1,334,536 | +1.1% | 2.49% | -18.8% |
Q1 2020 | $28,911,000 | – | 1,319,536 | – | 3.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |